Global Immortalized Cell Line Market Research Report: By Method (Virus Induction, HTERT Expression, Others), Application (Diagnostics, Drug Discovery, Vaccine Production, Tissue Engineering & Regenerative Medicine), End-User – Global Forecast Till 2023
Overview:
The global immortalized cell line market is spreading out due to the demand generated by the biotech and pharmaceutical industries. Immortalized cells do exist naturally, but in the form of a tumorous cell, however, it can be created artificially. Technological advancements enabled researchers to immortalize and culture these cells for several generations to ensure quality experiments. Some of the prominent cells that have been immortalized are HepaRD and Hep G2. The cells have made a significant contribution in the field of drug discovery and other researches to develop treatment strategies for various diseases. The global immortalized cell line market is expecting a robust growth by 9.30% CAGR during the forecast period (2018-2023), and the market can easily cross a total valuation of USD 4,100 million, proclaims Market Research Future (MRFR) in a published report. The report further includes segmentations, detailed analysis of the competitive landscape, expert tips, and factors that can influence the market considerably.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/751
Among the major factors, the global immortalized cell line market is gaining foothold owing to researches conducted by the biotech and pharmaceutical companies to deliver better drugs. Researches regarding cancer treatment and organ transplants are promoting regional markets. The effectiveness and efficiency of the research methods have made it an essential part of the cancer cure determination. The global immortalized cell line market is poised to become even more lucrative in the coming years as various research sectors regarding drug development are diversifying tests to develop drugs for other diseases as well.
However, stringent regulatory and licensing norms are with high initial investment can detract the immortalized cell line market from having the desired growth during the forecast period. The initial culture laboratory for such researches incurs a high cost. But governments are planning on promoting such researches for better immortalized cell line market prospect.
Competitive Landscape:
Prominent players profiled in the immortalized cell line market report are –
- Lonza Group AG
- Thermo Fisher Scientific
- Merck KGaA
- ATCC (American Type Culture Collection Inc.)
- Valneva
- Sartorius AG
- Wuxi App Tec
- European Collection of Authenticated Cell Cultures (ECACC)
- Selexis SA
- Corning Incorporated
Segmentation:
The report published by MRFR on the immortalized cell line market can be segmented by the method, application, and end-user.
Based on the method, the immortalized cell line market can be segmented into virus induction, hTERT expression, inactivation of tumor suppression genes, and others. Virus induction segment tops the market segment.
By application, the immortalized cell line market comprises diagnostics, vaccine production, drug discovery, tissue engineering and regenerative medicine, and others. Vaccine production segment is estimated to gain the fastest CAGR during the forecast period due to the growth in the wide applications in vaccine productions.
By end-user, the immortalized cell line market can be segmented into pharmaceutical and biopharmaceutical companies, research laboratories, Contract Research Organizations (CROs), and others. The pharmaceutical and biopharmaceutical companies segment is to retain its premier position during the forecast period.
Regional Analysis:
Geographical analysis of the global immortalized cell line market includes namely the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas market is leading the chart with the maximum market share of the revenue. The region has the superior infrastructure and invests substantial amount for research and development purposes. Owing to these two major factors, the region is enjoying substantial growth.
Europe is also spending heavily on better drug development. The region has several companies that are impacting the global market with mergers and acquisitions, and also by developing new drugs. Relatively higher customer awareness in the Americas and Europe are promoting the market.
The APAC market is gaining more as many market titans are looking at the region as a very good market investment plan owing to cost-effective resources.
Global Immortalized Cell Line Market – Competitive Analysis
Highly competitive, the Immortalized Cell Line Market appears to be fragmented owing to the presence of several large and small-scale players. These players invest substantially in R&D to develop advanced sensors. High potential growth opportunities that the market demonstrates are in turn, attracting several new entrants to the market, further intensifying the competition in the market.
Well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, partnership, and product & technology launch in order to gain a competitive advantage in this market and to maintain their market positions.
Augmenting government initiatives aimed at enhancing Genetic engineering capabilities is anticipated to present the market with high growth potential. This, in turn, has significantly increased R&D activities & programs, and fund allotment for R&D.
Industry/Innovations/Related News:
January 16, 2019 —- Sekisui XenoTech LLC (the US), the official distributor of JCRB cell lines in North America and a leading provider of in-vitro drug metabolism, Drug-Drug Interaction (DDI) studies, and the evaluation of drug candidates as substrates announced the expansion of its partnership agreement with the National Institute of Biomedical Innovation (NIBIO – Japan) to include distribution to Europe.
This deed allows Sekisui XenoTech to increase the utilization of its technologies among the scientists in both regions i.e. Europe & North America.
November 16, 2018 — National Institute for Environmental Studies (NIES – Japan), a research institute announced its successful endeavor in obtaining the immortalized avian cells with cell cycle regulation genes expression. The group had initiated a primary cell culture project aimed at preserving endangered avian species in Japan, such as the Okinawa rail.
As to overcome these cell culture limitations, primary cells must be immortalized, the primary cells cannot be cultured indefinitely due to the cellular senescence and stresses caused by cell culture.
Related Reports:
Cell Therapy Market Research Report- Global Forecast till 2023
Cell Isolation Market Research Report – Forecast to 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: www.marketresearchfuture.com/reports/immortalized-cell-line-market-751